V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006308 | 10004125 | 1.76 | 74.7 | Palliative (P) | 2016-08-20 | 2016-09-16 | Azacitidine | 02 | N | 10382324 | AZACITIDINE |
| 10006309 | 10007168 | null | 73.5 | Adjuvant (A) | null | 2018-03-15 | CARBOPLATIN + PACLITAXEL | N | N | 10382357 | CARBOPLATIN + PACLITAXEL |
| 10006310 | 10004129 | 1.78 | null | Palliative (P) | 2015-10-21 | 2015-10-22 | BCG Intravesical | N | N | 10382789 | BEVACIZUMAB |
| 10006311 | 10004130 | null | 60 | Palliative (P) | 2018-02-11 | 2018-02-12 | Capecitabine | N | N | 10382905 | CAPECITABINE |
| 10006312 | 10004132 | 1.82 | 91 | Adjuvant (A) | 2014-11-21 | 2015-04-12 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10382911 | CTD |
| 10006313 | 10004133 | 1.67 | 50.2 | Adjuvant (A) | 2017-12-28 | 2017-12-29 | Fluorouricil + Folonic Acid (MdG) | N | N | 10383186 | LENALIDOMIDE |
| 10006314 | 10004134 | 1.82 | 83.6 | Palliative (P) | 2017-02-25 | 2017-03-12 | CARBOPLATIN + ETOPOSIDE | N | N | 10383455 | CARBOPLATIN + ETOPOSIDE |
| 10006315 | 10007170 | 1.62 | 65.9 | Adjuvant (A) | 2017-07-21 | 2017-07-23 | Gemcitabine + Methylprednisolone | 02 | N | 10383653 | IBRUTINIB |
| 10006316 | 10007170 | 1.78 | null | Curative (C) | 2018-05-18 | 2018-06-01 | GEMCARBO | 01 | N | 10383653 | CTD |
| 10006317 | 10004135 | 1.65 | 90 | Curative (C) | 2016-05-04 | 2016-05-04 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 10384003 | IBRUTINIB |
| 10006318 | 10004136 | 1.63 | 68 | Palliative (P) | 2018-08-10 | 2018-08-22 | Carboplatin + Etoposide IV 3 day | null | null | 10384069 | CARBOPLATIN + ETOPOSIDE |
| 10006319 | 10004136 | 1.8 | 53.9 | Palliative (P) | 2017-03-29 | 2017-08-06 | GEMCITABINE | 2 | N | 10384069 | BEVACIZUMAB |
| 10006320 | 10004136 | 0 | 68.4 | Palliative (P) | 2017-07-06 | 2017-07-06 | BENDAMUSTINE + RITUXIMAB | 2 | N | 10384069 | BENDAMUSTINE + RITUXIMAB |
| 10006321 | 10004136 | 1.64 | 80.2 | Curative (C) | 2018-04-04 | 2018-04-04 | Bevacizumab | N | N | 10384069 | CTD |
| 10006322 | 10004136 | 1.76 | null | Palliative (P) | 2019-03-02 | 2019-04-25 | Carboplatin + Pemetrexed | 2 | null | 10384069 | CARBOPLATIN |
| 10006323 | 10004136 | 1.7 | null | Neo-adjuvant (N) | 2017-07-17 | 2017-07-17 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10384069 | ABIRATERONE |
| 10006324 | 10004137 | 1.78 | 93 | Adjuvant (A) | 2018-01-23 | 2018-06-02 | Trial Unspecified | N | null | 10384677 | TRIAL |
| 10006325 | 10004138 | null | 74 | Curative (C) | 2015-10-06 | 2015-11-04 | Carboplatin + Vinorelbine IV &PO D8 | N | N | 10385226 | IBRUTINIB |
| 10006326 | 10004139 | 1.64 | null | Palliative (P) | 2018-01-24 | 2018-02-14 | Carboplatin + Paclitaxel (weekly) | 2 | N | 10385236 | CARBOPLATIN + PACLITAXEL |
| 10006327 | 10004140 | 1.82 | 97 | Palliative (P) | 2014-08-29 | 2014-08-29 | IBRUTINIB | 02 | N | 10385370 | NOT MATCHED |
| 10006328 | 10004142 | 1.65 | 39.7 | Disease modification (D) | null | 2017-11-15 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10385413 | BEVACIZUMAB |
| 10006329 | 10004145 | 1.81 | 84 | Palliative (P) | 2018-09-18 | 2018-09-26 | Carboplatin + Etoposide iv&po | 02 | null | 10385482 | CARBOPLATIN + ETOPOSIDE |
| 10006330 | 10004145 | 1.63 | null | Palliative (P) | 2017-07-25 | 2017-07-25 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10385482 | BENDAMUSTINE + RITUXIMAB |
| 10006331 | 10004145 | 1.74 | 87 | Curative (C) | 2016-05-25 | 2016-05-25 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10385482 | BENDAMUSTINE + RITUXIMAB |
| 10006332 | 10004146 | 1.7 | 88.5 | Palliative (P) | 2016-04-02 | 2016-04-02 | BCG Intravesical | N | N | 10385735 | GEMCARBO |
| 10006333 | 10004147 | 1.64 | null | Palliative (P) | 2018-06-03 | 2018-06-26 | null | 2 | N | 10386221 | IBRUTINIB |
| 10006334 | 10007176 | 1.72 | 71.2 | Adjuvant (A) | 2018-11-19 | 2018-11-25 | CARBOPLATIN + PACLITAXEL | N | N | 10386223 | CARBOPLATIN + PACLITAXEL |
| 10006335 | 10007176 | 1.62 | 68.5 | Palliative (P) | 2016-03-03 | 2016-06-23 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 10386223 | CARBOPLATIN + PACLITAXEL |
| 10006336 | 10007176 | 1.65 | null | Not known (9) | 2018-10-14 | 2019-01-15 | GO2 TRIAL | 02 | N | 10386223 | TRIAL |
| 10006337 | 10004148 | 1.71 | 68.1 | Curative (C) | 2018-11-13 | 2018-11-14 | BCG Intravesical | 2 | N | 10386391 | CVP R |
| 10006338 | 10004149 | 1.85 | 75.2 | Palliative (P) | 2018-12-07 | 2018-12-22 | GEMCARBO | N | N | 10386550 | CVP R |
| 10006339 | 10004151 | 1.68 | 42.3 | Curative (C) | 2018-05-02 | 2018-05-02 | Carboplatin 21day + Paclitaxel 7day | 02 | N | 10386677 | CARBOPLATIN + PACLITAXEL |
| 10006340 | 10004151 | 1.76 | 0 | Palliative (P) | 2017-09-13 | 2017-09-17 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 10386677 | BENDAMUSTINE + RITUXIMAB |
| 10006341 | 10004152 | 1.84 | 85.5 | Disease modification (D) | 2016-10-14 | 2016-10-14 | Azacitidine | N | null | 10387212 | AZACITIDINE |
| 10006342 | 10004153 | 1.83 | 81.8 | Palliative (P) | 2019-08-01 | 2019-09-06 | CTD Attenuated (Thalidomide 50mg) | N | N | 10387467 | CTD |
| 10006343 | 10004154 | 1.81 | 90.9 | Curative (C) | 2013-04-25 | 2013-06-05 | Carboplatin 21day + Paclitaxel 7day | N | N | 10389714 | CARBOPLATIN + PACLITAXEL |
| 10006344 | 10004155 | 1.7 | 65.3 | Palliative (P) | 2018-07-03 | 2018-07-08 | Pemetrexed | 02 | N | 10408776 | CTD |
| 10006345 | 10004155 | 1.7 | 68.1 | Disease modification (D) | 2018-01-30 | 2018-02-13 | BENDAMUSTINE + RITUXIMAB | 2 | N | 10408776 | BENDAMUSTINE + RITUXIMAB |
| 10006346 | 10004157 | 1.75 | 97 | Palliative (P) | 2017-10-04 | 2018-03-19 | IBRUTINIB | N | N | 10408938 | BEVACIZUMAB |
| 10006347 | 10004157 | 1.55 | 82 | Palliative (P) | null | 2018-12-01 | null | N | N | 10408938 | LENALIDOMIDE |
| 10006348 | 10004158 | 1.63 | 52.4 | Palliative (P) | 2018-01-29 | 2018-02-12 | Lenalidomide 5mg (Cycle 1 to 25) | N | N | 10409013 | CTD |
| 10006349 | 10004158 | 1.55 | 64 | Palliative (P) | 2017-02-09 | 2017-03-10 | IBRUTINIB | N | N | 10409013 | CARBOPLATIN |
| 10006350 | 10004158 | 1.58 | 65.6 | Palliative (P) | null | 2015-05-17 | IBRUTINIB | N | N | 10409013 | IBRUTINIB |
| 10006351 | 10004160 | 1.95 | 94 | Curative (C) | 2017-11-10 | 2017-11-16 | Trial Unspecified | N | N | 10409034 | TRIAL |
| 10006352 | 10004164 | 1.8 | 72 | Disease modification (D) | 2015-08-10 | 2015-08-10 | Trial Unspecified | 02 | N | 10409290 | TRIAL |
| 10006353 | 10004166 | null | 61.1 | Neo-adjuvant (N) | 2014-10-21 | 2015-08-15 | Capecitabine | N | N | 10409858 | CAPECITABINE |
| 10006354 | 10004167 | 1.83 | 77.7 | Palliative (P) | 2017-12-30 | 2018-02-15 | null | 2 | N | 10409858 | LENALIDOMIDE |
| 10006355 | 10004170 | 1.65 | 90.6 | Not known (9) | 1938-11-11 | 2015-05-10 | CARBOPLATIN + PACLITAXEL | N | N | 10410223 | CARBOPLATIN + PACLITAXEL |
| 10006356 | 10004171 | 1.75 | 71.1 | Palliative (P) | null | 2013-12-21 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | 10410233 | CARBOPLATIN + PEMETREXED |
| 10006357 | 10004172 | null | null | Palliative (P) | 2017-04-02 | 2017-04-15 | Bendamustine+Rituximab(Sub Courses) | N | N | 10410299 | BENDAMUSTINE + RITUXIMAB |